Janus Henderson Contrarian Fund EBIT

Janus Henderson Contrarian Fund (JCNRX) currently reports a EBIT of $480M as of December 2023. That compares with $530M in the prior-year period — down 8.0% year over year. That is above the sector sector average of $-25M. Use the charts on this page to explore Janus Henderson Contrarian Fund's EBIT history and peer comparisons.

Janus Henderson Contrarian Fund's EBIT decreased from $530M to $480M — a 8.0% year-over-year decrease (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Janus Henderson Contrarian Fund's EBIT of $480M is higher than the its sector sector average of $-25M. That is roughly 2008.9% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Janus Henderson Contrarian Fund reported $480M in EBIT as of December 2023. That compares with $530M in the prior-year period — down 8.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $480M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $-25M. From there, open related valuation or income-statement pages for Janus Henderson Contrarian Fund, and consider following JCNRX for alerts when major investors trade the stock.